1-1 of 1
Noah Kaynan, PhD
Close
Sort by
Journal Articles

Obinutuzumab Activates CD64 More Potently Than Other Anti-CD20 Antibodies in Chronic Lymphocytic Leukemia (CLL)

Shlomo Elias, MD PhD, Shira Kahlon, PhD, Rebecca Kotzur, B.Sc., Noah Kaynan, PhD, Ofer Mandelboim, PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 3022.
https://doi.org/10.1182/blood.V130.Suppl_1.3022.3022
Published: 2017